Germany has
had a dramatic spike in new cases over the past day. The country has hit a new
high of nearly 30-Thousand cases. And nearly 600 people have died - the highest
daily total yet. Weeks of partial lockdown haven't slowed the spread of
infection enough. Much tougher restrictions seem almost inevitable now -- with
political momentum building for a harder lockdown over the holidays.
The US
appears on the verge of approving the country's first coronavirus vaccine. An
expert panel of scientists and doctors have reviewed information on the shot,
and are recommending emergency use of the BioNTech-Pfizer vaccine. Their
endorsement paves the way for the country's Food and Drug Adminstration to
issue the necessary final approval. Once that happens, the first shots could be
given within days. Regulators in Britain and Canada have already approved the
BioNTech-Pfizer vaccine for use in their countries.
Indonesia
received its first shipment of COVID-19 vaccines from China this week as the
government prepares for a mass inoculation program. The vaccine, developed by
Sinovac Biotech, will be evaluated by the Indonesian Food and Drug Authority
for emergency use. Indonesian clerics are also expected to issue a halal
certification for the experimental drug. President Joko Widodo says
these are only the first steps, and more doses are on the way.
An experimental vaccine developed by French drugmaker Sanofi
and Britain's GlaxoSmithKline has shown an insufficient immune response in
clinical trials. The companies hope to come up with a more effective drug by
the end of 2021.
Australia has cancelled the production of its own COVID-19
vaccine -- after some trial participants returned false positive results for
HIV. The government said it would order other vaccines to make up the
shortfall.
And researchers say the global response to the pandemic has
driven a record 7-percent drop in annual CO2 emissions. The UN says they'd have
to continue to decline at that rate for the next decade to reach international
climate goals.
Sem comentários:
Enviar um comentário